Search for: "Otsuka Pharmaceutical Co., Ltd." Results 21 - 37 of 37
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 May 2018, 12:20 pm by Tom Lamb
The drug companies responsible for Rexulti in the US are Otsuka Pharmaceutical Co., Ltd. [read post]
5 Apr 2023, 5:18 am by Annsley Merelle Ward
Birrs LJ also ventured further than this and asserted that the court can determine the validity of a foreign patent if it is relevant to the enforcement of the contract in Otsuka Pharmaceutical Co Ltd v GW Pharma Ltd [2022] EWCA Civ 1462. [read post]
31 Jan 2015, 8:47 pm by Mark Summerfield
  The drug is marketed in Australia by Bristol-Meyers Squibb (BMS) as ABILIFY, under license from the patentee Otsuka Pharmaceutical Co., Ltd.The Full Court has upheld the earlier finding of a single judge of the court that the patent is valid, notwithstanding that there is prior art teaching which, if carried out in a particular manner, could result in the claimed product. [read post]
The first instances of the cases were invalidation trials at the JPO filed by a number of generic companies[1](i) Kyowa Pharmaceutical Industry Co., Ltd., (ii) Nichi-Iko Pharmaceutical Co., Ltd., (iii) Nipro Corporation, (iv) Towa Pharmaceutical Co., Ltd., (v) Meiji Seika Pharma Co., Ltd. and (vi) Ohara … Continue reading against a medical use patent of Otsuka… [read post]
14 May 2008, 9:35 pm
Snecama Aerospace Industry (Suzhou) Co., Ltd. and Messier-Dowty Aerospace (Suzhou) Co., Ltd., the two subsidiaries of the French-owned Safran Corporation and manufacturers of components parts of aircraft engines and landing gears, celebrated official opening on April 7 in SIP Suzhou Otsuka Pharmaceutical Co., Ltd., invested by the Japanese-owned Otsuka Pharmaceutical Co, held a foundation laying… [read post]
3 Mar 2013, 12:06 pm by Rajiv Kr. Choudhry
Granted Anoop K Joy 1251/KOL/2006 OTSUKA PHARMACEUTICAL CO. [read post]
24 Nov 2010, 12:37 am by Kelly
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd & Anor (IPKat) (The SPC blog) Sustiva (Efavirenz) - Brazil: Compulsory licensed Efavirenz will be manufactured by public Brazilian laboratories by end of 2008 (IP tango)   General A patent question of patents: Prof T Pogge's 'Health Impact Fund'… [read post]
16 Jun 2010, 3:02 pm
(Docket Report) US: Re-examination ordered on ‘expired’ Harvard Oncomouse patent (Patent Docs)   Products Abilify (Aripiprazole) – US: Patent infringement complaint following a Paragraph IV certification: Otsuka Pharmaceutical Co., Ltd. v. [read post]
18 Nov 2016, 12:44 am by John Collins
Swiss Claims – Direct Infringement In the Australian proceedings, the Court affirmed Justice Yates’ approach in Otsuka Pharmaceutical Co Ltd v Generic Health Pty Ltd (No 4) (2015) 113 IPR 191, namely that the question of infringement of Swiss type claims was viewed through the prism of paragraph (b) of the definition of “exploit” in Schedule 1 of the Patents Act, which extends infringement to the use of the claimed method via a… [read post]
4 Apr 2008, 1:00 am
- Counterfeit cash flooding the market: (Afro-IP), Debranded fakes for Liberia: an update: (Afro-IP), South African music industry blames pirates for falling sales of local artists: (Afro-IP), Plaintiff obtains interlocutory relief in patent case Sanitam Services Limited v Bins (Nairobi) Services Limited: (Afro-IP), South Africa – new patent judgments: Buckman Laboratories v Bromine Compounds; Northpark Trading 3 (Pty) Ltd v Ausplow (Pty) Ltd: (Afro-IP) … [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central nervous system stem cell and… [read post]
23 Dec 2007, 8:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalEvents in Bali heap further pressure on all IP owners: (IAM),Velcro defies generic claim in domain name battle: (OUT-LAW),ICANN forms group to hasten non-English domain names: (IP Justice)WTO members continue debate on geographical indications register: (Intellectual Property Watch),Creative Commons launches CCo and CC programs: (World IP Day),Green IP Strategy - risks… [read post]